Prot: RNX-AX204-101: A Multicenter, Two Part (Open-Label Single-Ascending Dose Followed by Double-Blind, Placebo-Controlled Repeat Dose) Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AXER-204 in Subjects with Chronic Spinal

Project: Research project

StatusActive
Effective start/end date7/17/197/17/22

Funding

  • Covance Inc. (Prot: RNX-AX204-101)
  • ReNetX Bio, Inc. (Prot: RNX-AX204-101)